Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancer
Clinical trial NCT00987766 · COMPLETED
Trial details
- NCT number
- NCT00987766
- Sponsor
- Vanderbilt-Ingram Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-11-01
- Primary completion
- 2013-07-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.